Overview
Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci.
Indication
For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae
Associated Conditions
- Acute Myocardial Infarction (AMI)
- Arterial Thromboembolism
- Arterial thrombosis
- Arteriovenous fistula occlusion
- Arteriovenous fistula thrombosis
- Arteriovenous occlusions
- Central Retinal Vein Occlusion (CRVO)
- Chronic Occlusive Arterial Disease
- Deep Vein Thrombosis
- Peripheral artery thrombosis
- Pulmonary Embolism
- Pulmonary Embolism Acute Massive
- Pulmonary Thromboembolism
- Acute Arterial Thromboembolism
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/08/09 | N/A | Not yet recruiting | |||
2018/07/23 | Not Applicable | UNKNOWN | |||
2018/03/14 | Phase 3 | Completed | |||
2017/06/01 | Phase 4 | UNKNOWN | |||
2016/09/08 | N/A | Withdrawn | |||
2014/07/08 | Phase 3 | Completed | |||
2014/05/30 | Phase 2 | Withdrawn | |||
2013/11/06 | Phase 2 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | ||
2011/10/13 | Not Applicable | Completed | Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital | ||
2011/02/28 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Recombinant Streptokinase for Injection | 国药准字S20020096 | 生物制品 | 注射剂(冻干粉针剂) | 6/22/2020 | |
| Recombinant Streptokinase for Injection | 国药准字S20053082 | 生物制品 | 注射剂(冻干粉针剂) | 6/22/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.